Tirzepatide is a GLP-1 + GIP dual-action agonist
This shift is certainly evident on German social media, which saw more than 463,000 obesity-related mentions between December 2024 and November 2025
GLP-1 Market Overview 2026 | Size, Share & Industry Trend 2034 REPORT DETAILS GLP-1 Market Summary The global GLP-1 market size was valued at USD 52.82 billion in 2025, growing at a CAGR of 10.9% during 20262034
This coordinated induction helps maintain redox balance in cancer cells by enhancing mitochondrial sulfide metabolism
This is in line with previous real-world studies reporting greater persistence and adherence for patients with T2D receiving treatment with once-weekly GLP-1 RAs rather than daily GLP-1 RAs
Mike Braun on Thursday directed the Indiana Family and Social Services Administration, which administers Medicaid benefits to 1.9 million Hoosiers, to participate in a federal initiative to cover GLP-1 medications for obesity